Items tagged with Access

Access to medicines resolution adopted by UN Human Rights Council (post)

A resolution on access to medicines proposed by a number of developing countries was adopted today (July 1) by the United Nations Human Rights Council, as well as a resolution on enhancing capacity-building in public health. This marks yet another United Nations fora in which developing countries seek to raise the issue of access to medicines, particularly with regard to high prices.

Global Fund results factsheet (post)

GENEVA – Ahead of next week’s International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today (July 13) released results that show a significant increase in the number of people being treated for HIV.

Never again let people die because medicines are too expensive (post)

• UN Secretary-General Ban Ki-Moon to receive memorandum of demands in Durban
• UN High Level Panel provides unique opportunity for governments to make historic changes in healthcare.

Durban, 17 July 2016: On the eve of the 21st International AIDS Conference, civil society organisations from across the world call on world leaders to take decisive steps to ensure that the nightmare of people not being able to afford AIDS medicines will not be repeated for people with other diseases, including HIV co-infections. We make this call in Durban, South Africa, where on the morning of 18 July we will hand a memorandum of demands to United Nations Secretary-General Ban Ki-Moon.

Pricing dispute hits supply of TB drugs in Pakistan (post)

Swiss pharmaceuticals firm Novartis AG said it has stopped making tuberculosis drugs in Pakistan in a dispute over pricing, prompting fears of a health crisis due to a shortage of drugs in a country with the world's fifth-highest TB rates.

Universal treatment of multidrug-resistant TB is possible within current budgets with generic production (post)

Generic production could make novel multidrug-resistant tuberculosis (MDR-TB) regimens available for US $53–507 per treatment course according to data presented at TB2016.

Global Drug Facility 2016 Catalogue (post)

The Stop TB Partnership's Global Drug Facility (GDF) has published its 2016 Catalogue. The catalogue details prices and descriptions of products that can be ordered through GDF. Countries and programmes that enable health care providers to treat patients according to the latest WHO treatment guidelines can procure quality-assured products through GDF.

Multidrug-resistant TB treatment in North Korea: is scale-up possible? (post)

Summary points

New TB drug for children introduced in Papua New Guinea (post)

A new tuberculosis (TB) drug for children was launched today (August 9) by the PNG Paediatric Society, in partnership with World Health Organisation, National Department of Health, NCD Health, Port Moresby General Hospital (PMGH) and Exxon Mobil.

First govt-funded bedaquiline treatment for TB initiated in Mumbai (post)

The beginning of bedaquiline medication will be a boost in the fight against the bacterial infection which has caused a rising incidence of multidrug-resistant (MDR-) and extensively drug-resistant (XDR-)TB cases in Mumbai.

Eugene Bell Foundation calls for support to treat more TB patients in North Korea (post)

SEOUL, Aug. 17 -- The head of the Eugene Bell Foundation Korea on Wednesday voiced hope that more tuberculosis patients in North Korea could receive timely medication even at a time of heightened inter-Korean tensions.